These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
66 related items for PubMed ID: 10903908
1. A redox-inactive thioredoxin reduces growth and enhances apoptosis in WEHI7.2 cells. Freemerman AJ, Powis G. Biochem Biophys Res Commun; 2000 Jul 21; 274(1):136-41. PubMed ID: 10903908 [Abstract] [Full Text] [Related]
2. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Baker A, Payne CM, Briehl MM, Powis G. Cancer Res; 1997 Nov 15; 57(22):5162-7. PubMed ID: 9371519 [Abstract] [Full Text] [Related]
3. Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin. Berggren MI, Husbeck B, Samulitis B, Baker AF, Gallegos A, Powis G. Arch Biochem Biophys; 2001 Aug 01; 392(1):103-9. PubMed ID: 11469800 [Abstract] [Full Text] [Related]
5. Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth. Tome ME, Baker AF, Powis G, Payne CM, Briehl MM. Cancer Res; 2001 Mar 15; 61(6):2766-73. PubMed ID: 11289160 [Abstract] [Full Text] [Related]
6. Selenium and the thioredoxin redox system: effects on cell growth and death. Powis G, Gasdaska JR, Gasdaska PY, Berggren M, Kirkpatrick DL, Engman L, Cotgreave IA, Angulo M, Baker A. Oncol Res; 1997 Mar 15; 9(6-7):303-12. PubMed ID: 9406236 [Abstract] [Full Text] [Related]
7. Inhibition of protein kinase Calpha enhances anticancer agent-induced loss of anchorage-independent growth regardless of protection against apoptosis by Bcl-2. Huigsloot M, Tijdens RB, van de Water B. Mol Pharmacol; 2003 Oct 15; 64(4):965-73. PubMed ID: 14500753 [Abstract] [Full Text] [Related]
8. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Yokomizo A, Ono M, Nanri H, Makino Y, Ohga T, Wada M, Okamoto T, Yodoi J, Kuwano M, Kohno K. Cancer Res; 1995 Oct 01; 55(19):4293-6. PubMed ID: 7671238 [Abstract] [Full Text] [Related]
9. Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system. Jönsson-Videsäter K, Björkhem-Bergman L, Hossain A, Söderberg A, Eriksson LC, Paul C, Rosén A, Björnstedt M. Biochem Pharmacol; 2004 Feb 01; 67(3):513-22. PubMed ID: 15037203 [Abstract] [Full Text] [Related]
10. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. Gasdaska JR, Berggren M, Powis G. Cell Growth Differ; 1995 Dec 01; 6(12):1643-50. PubMed ID: 9019170 [Abstract] [Full Text] [Related]
11. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer. Baker AF, Koh MY, Williams RR, James B, Wang H, Tate WR, Gallegos A, Von Hoff DD, Han H, Powis G. Pancreas; 2008 Mar 01; 36(2):178-86. PubMed ID: 18376310 [Abstract] [Full Text] [Related]
12. Thioredoxin is downstream of Smad7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer. Arnold NB, Ketterer K, Kleeff J, Friess H, Büchler MW, Korc M. Cancer Res; 2004 May 15; 64(10):3599-606. PubMed ID: 15150118 [Abstract] [Full Text] [Related]
13. Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis. Wang Z, Rong YP, Malone MH, Davis MC, Zhong F, Distelhorst CW. Oncogene; 2006 Mar 23; 25(13):1903-13. PubMed ID: 16301999 [Abstract] [Full Text] [Related]
14. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K. Int J Oncol; 2003 Sep 23; 23(3):665-72. PubMed ID: 12888902 [Abstract] [Full Text] [Related]
15. Thymocytes selected for resistance to hydrogen peroxide show altered antioxidant enzyme profiles and resistance to dexamethasone-induced apoptosis. Tome ME, Briehl MM. Cell Death Differ; 2001 Sep 23; 8(9):953-61. PubMed ID: 11526450 [Abstract] [Full Text] [Related]
16. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Stepczynska A, Lauber K, Engels IH, Janssen O, Kabelitz D, Wesselborg S, Schulze-Osthoff K. Oncogene; 2001 Mar 08; 20(10):1193-202. PubMed ID: 11313863 [Abstract] [Full Text] [Related]
17. Thioredoxin redox control of cell growth and death and the effects of inhibitors. Powis G, Kirkpatrick DL, Angulo M, Baker A. Chem Biol Interact; 1998 Apr 24; 111-112():23-34. PubMed ID: 9679540 [Abstract] [Full Text] [Related]
18. Changes in phosphate metabolism in thymoma cells suggest mechanisms for resistance to dexamethasone-induced apoptosis. A 31P NMR spectroscopic study of cell extracts. Lutz NW, Tome ME, Aiken NR, Briehl MM. NMR Biomed; 2002 Aug 24; 15(5):356-66. PubMed ID: 12203227 [Abstract] [Full Text] [Related]
19. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific. Kissel CK, Schadendorf D, Röckmann H. Melanoma Res; 2006 Dec 24; 16(6):527-35. PubMed ID: 17119454 [Abstract] [Full Text] [Related]
20. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation. Koceva-Chyła A, Jedrzejczak M, Skierski J, Kania K, Jóźwiak Z. Apoptosis; 2005 Dec 24; 10(6):1497-514. PubMed ID: 16215684 [Abstract] [Full Text] [Related] Page: [Next] [New Search]